Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and efficacy of lubiprostone in a
pediatric population with constipation, including the pharmacokinetics of lubiprostone, in a
subset of patients.
Phase:
Phase 4
Details
Lead Sponsor:
Sucampo Pharma Americas, LLC Sucampo Pharmaceuticals, Inc.